Scorpion team lands $1.9B Novartis deal with new biotech

Novartis has signed a cancer drug deal worth up to $1.9B with Antares Therapeutics, which spun out of Scorpion Therapeutics ...
The Caledonian-Record

AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen ...

OCALA, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today highlighted the significant progress achieved across its pancreatic cancer development program ...
guardian.co.tt

Manning: THA entitled to seek $4.12B funding

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...
guardian.co.tt

Sturge backs US Navy SEAL presence in T&T: Sovereignty not under threat

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Westinghouse CEO praises DOE's $17.5B loan program as key to nuclear buildout

Westinghouse CEO Dan Sumner discusses how the Department of Energy's $17.5 billion loan program will accelerate nuclear ...